Automated Control of End-tidal Volatile Anesthetic Concentration

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The new MIRUS system as well as the established AnaConDa system uses a reflector to conserve volatile anaesthetics (VA). Both systems act with commercially available ICU ventilators. In contrast to AnaConDa the MIRUS includes an automated control of end-tidal VA concentrations. In this study the investigators compared feasibility, costs and recovery times after anaesthesia with isoflurane (ISO), sevoflurane (SEVO) or desflurane (DES) in ventilated and spontaneously breathing patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ruhr University of Bochum
• Treatments: Anesthetics; Desflurane; Isoflurane; Sevoflurane

Criteria

Inclusion Criteria:

• Signing of the informed consent document (patient or relatives).

• Patient age 18 years or older.

• ASA I-III

Exclusion Criteria:

• ASA IV patients

• Epidural or spinal analgesia

• Allergy or known hypersensitivity to any of the study drugs

• Patients with known or suspected genetic susceptibility to malignant hyperthermia

• Previous participation in this trial

• Participation in another clinical trial within 4 weeks prior to selection.

• Pregnant women